Sixty-six years have elapsed since the discovery of fetuin in 1944, but its importance in
mammalian physiology has only recently been appreciated. Fetuin, first isolated from fetal …

Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46 kDa hepatocyte
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …

Fetuin-A (α2-Heremans-Schmid glycoprotein), a circulating glycoprotein, can inhibit insulin
signaling both in vivo and in vitro. Recently, we and another independent group have shown …

Objective Nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic
syndrome (M et S) is closely associated with an increased risk of cardiovascular disease …

Background—Elevated circulating levels of fetuin-A in blood have been associated with
increased risk of cardiovascular disease. The goal of our study was to prospectively …

Calcium and phosphate are the principle ions involved in the deposition of mineral in the
human body. Inhibitors of mineralisation are essential for the prevention of ectopic mineral …

Fetuin was first isolated from bovine serum in 1944. It is now most commonly known as
either fetuin-A or alpha-2-HS-glycoprotein (AHSG), the protein product of Ahsg gene. A …

In past decades, extraosseous (including cardiovascular) calcification was predominantly
regarded as a passive process of limited pathophysiological significance. It was thought that …

Evidence is provided from studies on natural and artificial biofluids that the sequestration of
amorphous calcium phosphate by peptides or proteins to form nanocluster complexes is of …

Objectives The liver‐secreted protein fetuin‐A is associated with insulin resistance,
metabolic syndrome, type 2 diabetes and atherosclerosis. We examined the effect of caloric …